Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Comet Bio Awarded by Frost & Sullivan for its Arrabina(TM) Prebiotic Fiber

Comet Bio's use of upcycled crop leftovers to produce Arrabina ™ addresses consumer demand for sustainably sourced, clean label ingredients SANTA CLARA, Calif., Nov. 11, 2020 /PRNewswire/ -- Based on its recent analysis of sustainable dietary fiber products for the North American food and bevera...

2020-11-11 01:15 1759

Comet Bio Awarded by Frost & Sullivan for its Arrabina(TM) Prebiotic Fiber

FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform

World Leader in Fibroblast Technology Advances Intellectual Property Position with their 250th Patent Filed Today HOUSTON, Nov. 10, 2020 /PRNewswire/ -- FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibrob...

2020-11-10 22:37 1475

PPSS Group: Critical Advancement in Knife Protection

WETHERBY, United Kingdom, 10 November 2020 /PRNewswire/ -- Based on a comprehensive understanding of today's most realistic threats faced by homeland and private security professionals, PPSS Group have today announced an official replacement for their highly acclaimed polycarbonate-basedstab resi...

2020-11-10 22:00 2403

PPSS Group: Critical Advancement in Knife Protection

iNTERFACEWARE Inc. will be moving to a new office as of November 1st, 2020

TORONTO, Nov. 10, 2020 /PRNewswire/ -- iNTERFACEWARE Inc., developer of IGUANA®, the market leading health integration engine, announced today it is moving. The Toronto, Canada based company has been developing health integration solutions for over 20 years and is currently serving over 800 cust...

2020-11-10 22:00 1036

Dymicron™ appoints Armen Khachatryan, M.D. to Board of Directors

OREM, Utah, Nov. 10, 2020 /PRNewswire/ -- Dymicron, a privately held, innovative medical device company developing a next generation cervical artificial disc, Triadyme-C™, with a proprietary polycrystalline diamond material and novel, Tri-Lobe articulating design, today announced thatArmen Khach...

2020-11-10 21:15 1181

German MECOTEC Group launches one-stop-solution for deep-freeze, transport, storage and distribution for COVID-19-Vaccines with its first Mobile Hybrid Container

BITTERFELD-WOLFEN, Germany, Nov. 10, 2020 /PRNewswire/ -- Vaccine manufacturers, transport and storage providers are facing major challenges in the fight against the coronavirus. MECOTEC Group has announced a complete-one-stop-solution consisting of: 1. Deep-freeze cooling + 2. Transport + 3. St...

2020-11-10 19:52 1459

German MECOTEC Group launches one-stop-solution for deep-freeze, transport, storage and distribution for COVID-19-Vaccines with its first Mobile Hybrid Container

Zymo Research Obtains CE IVD Mark for its Quick SARS-CoV-2 Multiplex Kit

Low cost, high-sensitivity diagnostic test for COVID-19 detection IRVINE, Calif., Nov. 10, 2020 /PRNewswire/ -- Zymo Research announced today that it obtained a CE IVD mark for theQuick SARS-CoV-2 Multiplex Kit in compliance with the Directive 98/79/EC of the European Parliament and of the Counc...

2020-11-10 16:00 2101

Zymo Research Obtains CE IVD Mark for its Quick SARS-CoV-2 Multiplex Kit

mdgroup Joins The Beryl Institute Community

LONDON, Nov. 10, 2020 /PRNewswire/ -- mdgroup, a global digital and patient services company, recently joined The Beryl Institute community as an organisational member. Organisational members create market distinction by supporting a culture where staff at all levels have access to patient exper...

2020-11-10 16:00 1025

Inspiration Capital Partners becomes a strategic investor of New Frontier Vitality

HONG KONG, Nov. 10, 2020 /PRNewswire/ -- Inspiration Capital Partners ("ICP") today announced that private equity funds advised by ICP have become strategic capital partners and investors of New Frontier Vitality ("NFV"), the leading integrated post-acute and geriatric healthcare platform inChina...

2020-11-10 15:24 3656

Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine

BASEL, Switzerland, Nov. 10, 2020 /PRNewswire/ -- The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for Swiss Rockets AG. ABasel-based subsidiary, RocketVax AG, was founded to utilize innovative Swiss technologies and expertise to achieve this goal. "The...

2020-11-10 09:00 1735

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen

BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharma...

2020-11-10 09:00 2074

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen

Farrer Park Hospital Steps Up Prostate Cancer Treatment with Lutetium-177 PSMA Therapy

SINGAPORE, Nov. 10, 2020 /PRNewswire/ -- Farrer Park Hospital announced today the availability of Lutetium-177 Prostate Specific Membrane Antigen Therapy ("Lu177 PSMA Therapy"), a treatment for advanced prostate cancer.

2020-11-10 08:15 2384

Connect Biopharma to Present at the Jefferies Virtual London Healthcare Conference on November 17, 2020

SAN DIEGO and TAICANG, SUZHOU, China, Nov. 9, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, today announced thatZhe...

2020-11-09 21:00 1005

Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics

Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up...

2020-11-09 21:00 1483

Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors

TOULOUSE, France, Nov. 9, 2020 /PRNewswire/ -- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre ...

2020-11-09 20:57 1853

FTLife Launches "HealthCare 168 Plus" Critical Illness Protector

HONG KONG, Nov. 9, 2020 /PRNewswire/ -- FTLife Insurance Company Limited ("FTLife") today announced the launch of "HealthCare 168 Plus" Critical Illness Protector ("HealthCare 168 Plus" or "the Plan"), aggregated with two first-in-market[1] features including additional monthly financial support ...

2020-11-09 20:08 2521

OrbusNeich® Medical and P+F Products & Features® announce new partnership

Introducing a new portfolio of heart valve products aiming to restore health and extend life HONG KONG, Nov. 9, 2020 /PRNewswire/ -- OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive...

2020-11-09 19:00 2522

The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start

ZÜRICH, Nov. 9, 2020 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the SirPAD (Sirolimus in Peripheral Artery Disease) trial.

2020-11-09 18:55 2025

The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start

Covid-19 Vaccination Plan: Badan POM Set to Ensure and Safeguard the safety, efficacy, and quality of Covid-19 vaccine

* Prudent approach and usability are among the top priorities * Efforts are underway to provide the best efficacy for public at large JAKARTA, Indonesia, Nov. 9, 2020 /PRNewswire/ -- In a bid to support the government's plan to develop Covid-19 vaccine inIndonesia, the National Drug and Food ...

2020-11-09 17:25 2133

Covid-19 Vaccination Plan: Badan POM Set to Ensure and Safeguard the safety, efficacy, and quality of Covid-19 vaccine

SynAct Pharma Announces Positive Interim Phase 2 Data of AP1189 in Rheumatoid Arthritis

* The Data Safety Monitoring Board (DSMB) finds no safety concerns in the 50 mg and 100 mg dose cohorts * Signs of efficacy against rheumatoid arthritis was observed. Thus, the number of patients changing from the severe to the moderate Clinical Disease Activity Index (CDAI) score was higher ...

2020-11-09 15:22 1041

1 ... 399 400 401402403 404 405 ... 553